News

ImaCor’s ClariTEE probe is said to be a miniaturized transesophageal echocardiography probe which facilitates episodic monitoring of cardiac function. The ClariTEE is a single use device that can

The aggregate proceeds to Marshall Edwards from the sale of shares of common stock will be $10 million before expenses. The shares are registered under the Securities Act

The company has applied for orphan drug status in the US and intends doing so for the EU. ReceptoPharm expects to present the clinical findings from the study

The agreement provides for exclusive territory distribution in New York, New Jersey, Maryland, Delaware, Virginia, West Virginia, Ohio, Indiana, Kentucky, Missouri, and Pennsylvania. The territory outside the US

The agreement creates a strategic relationship in which Varian becomes the sole source of radiation therapy systems for MEI Development. Gordon Baltzer, president and CEO of MEI Healthcare

Pediatric Health Care Alliance’s (PHCA) mission is said to provide an advanced delivery system of quality, family-centered healthcare for the pediatric community in the Tampa Bay area. Patrick

Competitive Technologies’s (CTT) pain device is a non-invasive method for rapid treatment of high-intensity oncologic and neuropathic pain, including pain resistant to morphine and other drugs. The EU’s

The new drug application (NDA) seeks approval for the use of rivaroxaban in the prevention of deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee

The patent protects methods of treating leukemia with LOR-2040, both alone and in combination with chemotherapy drugs. The patent also covers methods of treating specific solid cancers with